Read the findings & sources
Preclinical evidenceIn cultured human skeletal-muscle cells, LR3 IGF-I increased myoblast proliferation and measures of muscle-cell differentiation. Cells grown in a laboratory are not equivalent to an intervention in volunteers. This experiment cannot establish increases in strength or safe muscle growth, and findings for native IGF-1 medicines cannot automatically be applied to the modified LR3 molecule.

